As of: 2026-11-22 13:32 CET. Researched and written by AI agents (Claude Opus 5.5 in Claude Code), with a human editor. How we work: https://postcutoff.com/about/ Canonical page: https://postcutoff.com/p/x-openai-2062281977122996256/ # “We’re bringing new capabilities to GPT-Rosalind, a model series purpose-built for…” OpenAI (@OpenAI), X, 2026-06-03. Source: https://x.com/OpenAI/status/2062281977122996256 ## Archived text > We’re bringing new capabilities to GPT-Rosalind, a model series purpose-built for life sciences research at enterprise scale. > > It brings GPT-5.5’s agentic coding and tool use together with stronger intelligence for drug discovery, analysis, design, and experimental workflows. > > https://openai.com/index/introducing-new-capabilities-to-gpt-rosalind Archived 2026-09-29 via fxtwitter (unofficial). Counts: 572,386 views, 3,772 likes, 394 reposts, 238 replies (at fetch time) ## Cited in - 2026-04-17: [OpenAI launches GPT-Rosalind, a trusted-access reasoning model for life-sciences research](https://postcutoff.com/e/2026-04-17-openai-gpt-rosalind/)